Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05514938 · ClinicalTrials.gov registry record · Phase 2
Polypill in Acute Coronary Syndrome
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT05514938 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 140 participants.
The verdict
NCT05514938, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
Acute coronary syndromes (ACS) represent a major contributor to mortality, morbidity, and healthcare costs. Effective therapies are widely available; however, adherence is low. This contributes to worse patient outcomes and increased risk of morbidity and mortality. The once-daily polypill leverages a population-based strategy that has previously demonstrated efficacy in improving adherence and access to therapy in low-resource settings, making it an innovative approach for improving post-ACS care. This study aims to investigate the utility of a polypill-based strategy for patients with ACS with drug eluting stent (DES) placement. The polypill will consist of a high-intensity statin (rosuvastatin 40 mg daily), aspirin 81 mg daily, and either clopidogrel 75 mg or prasugrel 10 mg daily.
Interventions
- DRUG Polypill
- DRUG Usual Care (individual medications prescribed by primary cardiologist)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2025-06-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05514938
The ClinicalTrials.gov registry entry for NCT05514938 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Polypill is the first listed.
NCT05514938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05514938 about?
NCT05514938 is a clinical study titled "Polypill in Acute Coronary Syndrome". Acute coronary syndromes (ACS) represent a major contributor to mortality, morbidity, and healthcare costs. Effective therapies are widely available; however, adherence is low. This contributes to worse patient outcomes and increased risk of morbidity and mortality. The once-daily polypill leverages...
What is the current status of trial NCT05514938?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2022-11-30. Estimated completion is 2025-06-05.
What interventions are being tested in trial NCT05514938?
The interventions under investigation include: Polypill (DRUG), Usual Care (individual medications prescribed by primary cardiologist) (DRUG).
Who is sponsoring clinical trial NCT05514938?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.